Skip to main content Skip to section navigation Skip to footer

ClearPoint Neuro, Inc.

Investor Relations

  • Investors
  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • clearpointneuro.com
This website uses cookies to improve your experience. ACCEPT REJECT

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Jun 20, 2024 8:45am EDT

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

Jun 01, 2024 9:00am EDT

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

May 07, 2024 4:05pm EDT

ClearPoint Neuro Reports First Quarter 2024 Results

May 02, 2024 4:05pm EDT

ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore

Apr 29, 2024 8:00am EDT

ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory

Apr 24, 2024 4:05pm EDT

ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System

Apr 23, 2024 4:05pm EDT

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024

Apr 16, 2024 4:05pm EDT

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

Mar 19, 2024 8:07am EDT

ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency

Mar 12, 2024 4:05pm EDT

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 35
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
ClearPoint Neuro, Inc. Youtube ClearPoint Neuro, Inc. Facebook ClearPoint Neuro, Inc. Twitter ClearPoint Neuro, Inc. LinkedIn ClearPoint Neuro, Inc. Instagram
©2025 ClearPoint Neuro, Inc. All Rights Reserved.
Privacy Policy Cookie Policy Terms of Use California Compliance Declaration Sitemap